BNTC Benitec Biopharma Inc.companySEC Filings & Insider Trading Activity 2026
Latest Benitec Biopharma Inc. (BNTC) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on September 22, 2025, a 10-Q quarterly report filed on May 14, 2026, an 8-K current report filed on May 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Benitec Biopharma Inc. (BNTC) (SEC CIK 1808898), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on Benitec Biopharma Inc.
Ask AI about BNTC filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting BNTC positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on BNTC.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate BNTC share value held by 13F filers tracked by SignalX, by quarter.
- BlackRock+193.4K (+19%)
- Citadel Advisors LLC+154.1K (+877%)
- State Street Corp+93.2K (+38%)
- Goldman Sachs Group+41.4K (+24%)
- Millennium Management+38.9K (+6%)
- Morgan Stanley29.5K (-50%)
- Wells Fargo & Co9.2K (-57%)
- Franklin Resources+2.38M
- Fifth Third Bancorp+106
- Vanguard Group Inc−1.17M
- JPMorgan Chase & Co−6.0K
Source: 13F-HR filings on SEC EDGAR (aggregated from 84 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest BNTC SEC filings in 2026?
Benitec Biopharma Inc. (BNTC) has filed a 10-K annual report on September 22, 2025, a 10-Q quarterly report on May 14, 2026, an 8-K current report on May 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did BNTC file its most recent 10-K annual report?
Benitec Biopharma Inc. (BNTC) filed its most recent 10-K annual report on September 22, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view BNTC 10-Q quarterly reports?
Benitec Biopharma Inc. (BNTC)'s most recent 10-Q quarterly report was filed on May 14, 2026. SignalX displays every BNTC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has BNTC filed recently?
Benitec Biopharma Inc. (BNTC)'s most recent 8-K was filed on May 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find BNTC insider trading activity (Form 4)?
SignalX aggregates every BNTC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does BNTC file with the SEC?
Benitec Biopharma Inc. (BNTC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new BNTC filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Benitec Biopharma Inc. (BNTC).
What is BNTC's SEC CIK number?
Benitec Biopharma Inc. (BNTC)'s SEC CIK (Central Index Key) number is 1808898. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1808898 to look up all BNTC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of Benitec Biopharma Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 46+ filings.